Platelet aggregation inhibitors/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Chris Day |
No edit summary |
||
Line 10: | Line 10: | ||
{{r|Anticoagulant}} | {{r|Anticoagulant}} | ||
{{r|Warfarin||**}} | {{r|Warfarin||**}} | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Hepatocellular cancer}} | |||
{{r|Diabetes mellitus type 2}} | |||
{{r|Platelet Glycoprotein GPIIb-IIIa Complex}} | |||
{{r|Platelet glycoprotein GPIIb-IIIa complex}} | |||
{{r|Cangrelor}} |
Latest revision as of 16:01, 4 October 2024
- See also changes related to Platelet aggregation inhibitors, or pages that link to Platelet aggregation inhibitors or to this page or whose text contains "Platelet aggregation inhibitors".
Parent topics
- Platelet activation [r]: Series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue, and release reactions. [e]
Subtopics
- Aspirin [r]: Common analgesic used for treating mild to moderate pain; protective against blood clots and heart disease when administered indefinitely in low doses [e]
- Anticoagulant [r]: Agents that prevent blood clotting. [e]
- Hepatocellular cancer [r]: Carcinoma derived from parenchymal cells of the liver, usually caused either by a viral hepatitide infection (hepatitis B or C) or cirrhosis. [e]
- Diabetes mellitus type 2 [r]: Medical condition characterised by glucose intolerance and hyperglycemia [e]
- Platelet Glycoprotein GPIIb-IIIa Complex [r]: Add brief definition or description
- Platelet glycoprotein GPIIb-IIIa complex [r]: Integrin receptor found on platelets for fibrinogen, and aids in platelet activation. [e]
- Cangrelor [r]: Add brief definition or description